OXER1/5-oxo-ETE GPCR Antibody [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-47238UV

Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
ELISA, Immunohistochemistry, Serum, Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
oxoeicosanoid(OXE) receptor 1. (Uniprot# Q8TDS5)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for OXER1/5-oxo-ETE GPCR Antibody [DyLight 350]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Serum
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OXER1
Long Name
Oxoeicosanoid Receptor 1
Alternate Names
GPR170
Gene Symbol
OXER1
Additional OXER1 Products
Product Documents for OXER1/5-oxo-ETE GPCR Antibody [DyLight 350]
Product Specific Notices for OXER1/5-oxo-ETE GPCR Antibody [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...